Ubs Group Ag Lixte Biotechnology Hldgs Inc Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

Shares

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Aug 13, 2024	BUY	N/A	235 Added 6.1%	4,088 $0
Q1 2024 May 13, 2024	BUY	N/A	3,643 Added 1734.76%	3,853 $0
Q4 2023 Feb 09, 2024	BUY	N/A	210 New	210 $0
Q1 2023 May 12, 2023	BUY	N/A	811 New	811 $0
Q3 2022 Nov 10, 2022	BUY	N/A	90 Added 1.19%	7,623 $0
Q2 2022 Aug 10, 2022	SELL	N/A	-1,067 Reduced 12.41%	7,533 $1,000
Q1 2022 May 16, 2022	BUY	N/A	2,350 Added 37.6%	8,600 $2,000
Q4 2021 Feb 14, 2022	SELL	N/A	-2,274 Reduced 26.68%	6,250 $3,000
Q3 2021 Nov 15, 2021	SELL	N/A	-510 Reduced 5.65%	8,524 $5,000
Q2 2021 Aug 13, 2021	BUY	N/A	1,855 Added 25.84%	9,034 $7,000
Q1 2021 May 12, 2021	SELL	N/A	-16,061 Reduced 69.11%	7,179 $6,000
Q4 2020 Feb 11, 2021	BUY	N/A	23,240 New	23,240 $21,000

Others Institutions Holding LIXTW

# of Institutions

4

Shares Held

86.6K

Call Options Held

0

Put Options Held

0

About LIXTE BIOTECHNOLOGY HLDGS INC

Ticker LIXTW

More about LIXTW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.